Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion type Assertion NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_head.
- NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion description "[The results of this retrospective study suggest that tailoring MMC therapy to individual patients with superficial bladder cancer on the basis of NQO1 genotype status is unlikely to be of clinical benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_provenance.
- NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion evidence source_evidence_literature NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_provenance.
- NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion SIO_000772 15375541 NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_provenance.
- NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion wasDerivedFrom befree-2016 NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_provenance.
- NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_assertion wasGeneratedBy ECO_0000203 NP460493.RANI5pW76Vy8kRfGDlIv79biEje4TgrCxeLBoe3vBFpeg130_provenance.